agonistically

1. Preperfusing with Bay K 8644 (500 nmol/L), an agonist of calcium channels, also eliminated the effect of Agm on carotid baroreceptor activity.

(4 )預(yù)先灌流Ca2 +通道激動(dòng)劑BayK 86 44 (5 0 0nmol/L)亦可取消Agm對(duì)竇神經(jīng)傳入放電的影響。

2. The SPECT imaging with 123 I AIBZM reflected the functional actitvity of striatal D 2R and might be valuable for predicting the patients' response to L dopa, especially D 2R agonist therapy for Parkinson's disease.

12 3I AIBZMSPECT顯像能反映D2 R功能狀態(tài) ,可能是預(yù)測(cè)PD患者對(duì)左旋多巴 ,尤其是D2 R激動(dòng)劑治療反應(yīng)性的一個(gè)指

3. Keywords M 1 receptor;reporter gene;agonist;high throughput screening （HTS）;

1受體;報(bào)告基因;激動(dòng)劑;高通量藥物篩選;

4. Keywords M_1 agonist;distance comparison method;pharmacophore model;database searching;

1受體激動(dòng)劑;距離比較法;藥效團(tuán)模型;數(shù)據(jù)庫(kù)搜索;

5. Keywords Type 2 diabetes;Insulin sensitivity;Peroxisome proliferators activated receptor;Agonist;Selective modulator;3D-QSAR;

2型糖尿病;胰島素敏感性;過氧化物酶體增殖因子激活受體;激動(dòng)劑;選擇性調(diào)節(jié)劑;三維定量構(gòu)效關(guān)系;

6. 1 Agata Mulak,Leszek Paradowski; Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients [J]; World Journal of Gastroenterology; 2006年10

2孫曉毅,王果,郭先娥,袁繼炎,史慧芬;巨結(jié)腸類緣性疾病肛管測(cè)壓、直腸黏膜活檢和鋇灌腸檢查的意義[J];中華小兒外科雜志;2004年04期

7. 5 - HT4 receptor partial agonist

5-HT4受體激動(dòng)劑

8. Effects of 5-hydroxytryptamine4 receptor agonist and antagonist on visceral sensitivity and plasma serotonin level in rats under partial restraint stress

5-羥色胺4受體在調(diào)節(jié)應(yīng)激大鼠內(nèi)臟敏感性中的作用

9. serotonergic agonist

5-羥色胺能激動(dòng)劑

10. Allo couldn’t inhibit increase in the PKA activity of forskolin , D1 receptor agonist SKF, ryanodine-induced;

Allo不能抑制AC激動(dòng)劑Forskolin、 D1受體激動(dòng)劑SKF(10mM)、細(xì)胞內(nèi)Ca2+庫(kù)釋放劑Ryanodine(1mM)引起的PKA活性的增加；

11. AT_ 2 agonist group (n=8) was treated with AT_ 2 agonist (CGP42112A) (i.p).

AT2 激動(dòng)劑組(8 只), 腹腔注射AT2激動(dòng)劑(CGP42112A);

12. Selective AT2 receptor agonist

AT2受體激動(dòng)劑

13. Cesium chloride is a blocker of K~+ channel which in turn prolongs repolarization, increases influx of Na~+/Ca~(2+) and thus EAD is induced. Mg~(2+) is an agonist of K~+ channel, therefore it antagonizes the action of CS~+.

Cs~+為細(xì)胞膜K~+通道阻滯劑,延長(zhǎng)復(fù)極時(shí)間,增加內(nèi)向Na~+/Ca~(2+)流,由此產(chǎn)生EAD,而Mg~(2+)為細(xì)胞膜K~+通道激動(dòng)劑,因此,Mg~(2+)對(duì)Cs~+具對(duì)抗作用。

14. ET 1 and the ETB agonist, sarafatoxin S6c increased BP to a greater extent in D 2+/+ than in D 2-/- mice.

ET 1和ETB激動(dòng)劑sarafatoxinS6c升高D2 +/ +鼠血壓強(qiáng)于D2 - / -鼠。

15. Effects of the GABAA-receptor Agonist and Antagonist on Fos Expression in Rat Piriform Cortex and Hippocampus and Their Relationship with Epilepsy

GABAA受體激動(dòng)劑和拮抗劑對(duì)大鼠梨形皮質(zhì)、海馬Fos表達(dá)的影響及其與癲癇發(fā)病的關(guān)系

16. Effects of repeated injection of GABAB receptor agonist baclofen on mean blood pressure in rats

GABAB受體激動(dòng)劑巴氯酚重復(fù)注射對(duì)大鼠血壓的影響

17. G ABAB agonist

GABAB激動(dòng)劑

18. LHRH agonist

LHRH促效劑:用于多種疾病的治療

19. Effects of LXR agonist on the expressions of iNOS and eNOS in aortic wall of ApoE-/-mice

LXR激動(dòng)劑對(duì)ApoE基因敲除小鼠動(dòng)脈壁iNOS和eNOS表達(dá)的影響

20. M3 receptor agonist

M3受體激動(dòng)劑

21. The M receptor agonist pilocarpine was similar to the effects of ACh.

M受體激動(dòng)劑毛果蕓香堿能產(chǎn)生與ACh相似的效應(yīng)。

22. peroxisome proliferator-activated receptor-γ agonist

PPAR-γ激動(dòng)劑

23. PPARα agonist

PPARα激動(dòng)劑

24. PPARγ agonist

PPARγ激動(dòng)劑

25. Repinotan is a highly potent and selective 5-HT_(1A) receptor full agonist developed by Bayer Corporation in USA. It is a putative neuroprotective compound in acute ischaemic stroke and traumatic brain injury.

Repinotan是拜爾公司開發(fā)的一個(gè)具有高結(jié)合親合力、高選擇性的5-HT_(1A)受體完全激動(dòng)劑，是公認(rèn)的神經(jīng)保護(hù)劑。

26. 2 summarizes the [ 5 S ] GTPS binding on m2AchR protein and m2AchR-Gila fusion protein in the existence of agonist Ach and Cch,or antagonist Atropine and AF-DX116 without GDP.

Table. 2顯示，在GDP零濃度時(shí)，Ach和Cch使mZAchR一Gila融合蛋白與[”5] GTp，s的結(jié)合量增大，而Atropine和AF一Dxll6則使之減小，且明顯高于同等條件下mZ AchR蛋白與[3，5] GT巧S的結(jié)合量;

27. BH3 interacting death agonist (tBid)

tBid

28. α2 -adrenoreceptor agonist

α2腎上腺素能受體

29. β - adrenergic agonist

β-興奮劑

30. β- adrenergic agonist

β-腎上腺素受體激動(dòng)劑

31. β-adrenergic agonist

β-腎上腺素能興奮劑

32. β2 - agonist

β2-受體激動(dòng)劑

33. 2 receptor agonist

β2受體激動(dòng)劑

34. β2-adrenergic receptor agonist

β2腎上腺素能受體激動(dòng)劑

35. β3-adrenergic receptor agonist

β3腎上腺素能受體激動(dòng)劑

36. We report a case of antecollis, or dropped head with Parkinson's disease (PD) induced by pramipexole, a nonergot dopamine agonist.

一80歲的女性帕金森病患者出現(xiàn)頸項(xiàng)前屈，表現(xiàn)為嚴(yán)重的頸反射，癥狀進(jìn)行性加重。

37. A sympathomimetic that acts mainly by causing release of norepinephrine but also has direct agonist activity at some adrenergic receptors.

一種擬交感神經(jīng)藥物，主要以引發(fā)去甲腎上腺素釋放起作用，對(duì)交感神經(jīng)受體也有直接的促進(jìn)作用。

38. Advair combines two components in one.Patients should have short acting beta agonist inhaler as rescue.

一般維持治療就是長(zhǎng)效的beta agonist, 擴(kuò)張支氣管的，外加inhaling steroid抗炎。

39. Different form antagonist that blocks the effect of agonist, inverse agonist produces opposite effect to that of agonist.

與阻斷激動(dòng)劑效應(yīng)的拮抗劑不同，反向激動(dòng)劑產(chǎn)生的效應(yīng)與激動(dòng)劑相反。

40. agonist muscle

主動(dòng)肌

41. Agonist muscle action

主動(dòng)肌動(dòng)作

42. acetylcholine agonist

乙酰膽堿拮抗劑

43. agonistic behavior The social interaction between members of a species, involving aggression or threat and conciliation or retreat. Agonist.

爭(zhēng)斗行為物種的個(gè)體之間的社會(huì)關(guān)系,包括進(jìn)攻或威脅。

44. Keywords metabotropic glutamate receptors;PC12 cells;cell survival;6-hydroxydopamine;glutamic acid;excitatory amino acid agonist;excitatory amino acid antagonist;

親代謝型谷氨酸受體;PC12細(xì)胞;細(xì)胞存活;6-羥基多巴胺;谷氨酸;興奮性氨基酸激動(dòng)劑;興奮性氨基酸拮抗劑;

45. These characteristics of a partial agonist may be useful in the development of competitive antagonists of KGF action.

作為一種不完全激動(dòng)劑，這些特性可能對(duì)發(fā)展KGF的競(jìng)爭(zhēng)性抑制劑活性有用。

46. The authors first tested the PPAR agonist rosiglitazone in combination with seeral different chemotherapeutics against arious cancer cell lines.

作者第一次測(cè)試PPAR激動(dòng)劑羅格列酮與不同的化療藥物聯(lián)合對(duì)不同癌細(xì)胞株的作用。

47. Gonadatropie releasing hormone agonist (GnRHa)

促性腺激素釋放激素激動(dòng)劑

48. Keywords Gonadotropin releasing hormone agonist;Down regulation;Ovarian response;Poor responder;

促性腺激素釋放激素激動(dòng)劑;降調(diào)節(jié);卵巢反應(yīng)性;低反應(yīng);

49. A Year effect on bone mineral density in the Treatment of Endometriosis with Gonadotropin Releasing Hormone Agonist Combined with Add back Therapy

促性腺激素釋放激素激動(dòng)劑及聯(lián)合激素反加療法治療子宮內(nèi)膜異位癥對(duì)骨密度1年的影響

50. Application of Gonadotropin-releasing Hormone Agonist for Triggering Ovulation in High Risk Gonadotropin Stimulating Cycles of Infertile Polycystic Ovary Syndrome Patients

促性腺激素釋放激素激動(dòng)劑在多囊卵巢綜合征促排卵高危周期中的應(yīng)用

51. Influence of gonadotropin-releasing hormone agonist on the effects of chemotherapy upon ovarian cancer: an experimental study with rat model

促性腺激素釋放激素激動(dòng)劑對(duì)卵巢癌大鼠化療效果的影響

52. Influences of gonadotropin releasing hormone agonist treatment on nitric oxide synthase expression in women with endometriosis and infertility

促性腺激素釋放激素激動(dòng)劑對(duì)子宮內(nèi)膜異位癥不孕患者在位內(nèi)膜一氧化氮合酶表達(dá)的影響

53. Effect of gonadotropin-releasing hormone agonist on prolactin production by human leiomyoma cells

促性腺激素釋放激素激動(dòng)劑對(duì)子宮肌瘤細(xì)胞泌乳素生成的作用

54. Gonadotropin-releasing hormone agonist inhibits estrone sulfatase expression of cystic endometriosis in the ovary.

促性腺激素釋放激素激動(dòng)劑抑制卵巢內(nèi)膜樣囊腫中雌酮硫酸酯酶的表達(dá)。

55. Effect of Gonadotropin Releasing Hormone Agonist Combined with Add-back Therapy on Bone Histomorphometric Parameters of Rats with Experimental Endometriosis

促性腺激素釋放激素激動(dòng)劑聯(lián)合反加療法治療大鼠子宮內(nèi)膜異位癥的骨形態(tài)計(jì)量學(xué)研究

56. gonadotrophie hormone releasing hormone agonist

促性腺激素釋放激素類似物

57. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.

促性腺激素釋放激素類似物聯(lián)合生長(zhǎng)激素治療對(duì)性早熟兒童成年身高的影響:具有深遠(yuǎn)意義。

58. gonadotrophin-releasing hormone agonist

促性腺激素釋放素

59. Keywords ovarian hyperstimulation;gonadotropin releasing hormone agonist （GnRH-a）;

關(guān)鍵詞促超排卵;促性腺激素釋放激素;

60. Keywords Uterine leiomyoma Mifepristone Long acting gonadotrophin releasing hormone agonist;

關(guān)鍵詞子宮肌瘤;米非司酮;長(zhǎng)效促性腺激素釋放激素;

61. Ca ~(2+)Concentration change in platelets activated by chemical agonist

化學(xué)誘導(dǎo)劑對(duì)血小板鈣離子濃度變化的影響

62. The averaged agonist EMG activity had significantly increased(P< 0. 05), but the restraint of the antagonistic muscles had not increased( P > 0. 05) .

原動(dòng)肌(股四頭肌)平均EMG活動(dòng)顯著增加(P<0.05),拮抗肌(摑繩肌)抑制活動(dòng)變化較小(P>0.05);

63. dual agonist

雙重激動(dòng)劑

64. Recent investigation suggested that inverse agonist has potential clinical application.

反向激動(dòng)劑有良好的臨床應(yīng)用前景。

65. The competition curves of inverse BDZ receptor agonist DMCM was illustrated in a biphasic way by a computer model of two sites.

反相激動(dòng)劑DMCM競(jìng)爭(zhēng)結(jié)合曲線亦具有雙位點(diǎn)結(jié)合特性。

66. Keywords Oral contraceptive Gonadotrophin releasing hormone agonist Polycystic ovarian syndrome Ovarian hyperstimulation syndrome;

口服避孕藥;促性腺激素釋放激素激動(dòng)劑;多囊卵巢綜合征;卵巢過度刺激綜合征;

67. Muscle cocontraction indices were derived for agonist and antagonist muscle pairings.

同時(shí)檢測(cè)配對(duì)的主動(dòng)肌與拮抗肌的肌肉協(xié)同攣縮指數(shù)。

68. Meanwhile,the effects of the PMA(PKC agonist),staurosporine(PKC inhibitor),8Br-cGMP(PKG agonist)and KT-5823(PKG inhibitor)on calcium sensitivity and the changes in PKC and PKG activities in SMA were observed following hemorrhagic shock.

同時(shí)觀察PKC、PKG活性調(diào)節(jié)劑對(duì)鈣敏感性的影響。 測(cè)定大鼠SMA的PKC、PKG活性變化,分析PKC、PKG活性變化與血管鈣敏感性變化間的關(guān)系。

69. Aspiratory β2-adrenergic agonist

吸入型β2受體激動(dòng)劑

70. Six hours after exposure, vasomotor and fibrinolytic function were assessed by means of intraarterial agonist infusions.

吸入汽車廢氣后6小時(shí)，血管收縮和溶解纖維蛋白的功能通過輸入動(dòng)脈激動(dòng)劑藥物進(jìn)行分析。

71. Without the influence of nerve and body fluid,I_1R agonist,Mox,acted directly on heart.

在不依賴中樞神經(jīng)系統(tǒng)和體液因素影響的情況下，I_1R激動(dòng)劑Mox可對(duì)心臟產(chǎn)生直接的作用。

72. In both receptors, the addition of cholesterol molecules led to a dramatic increase in agonist affinity;

在這兩種受體中，膽固醇分子的加入導(dǎo)致對(duì)激動(dòng)劑的親和力顯著增加；

73. In both receptors, the addition of cholesterol molecules led to a dramatic increase in agonist affinity; for oxytocin, it also increased stability.

在這兩種受體中，膽固醇分子的加入導(dǎo)致對(duì)激動(dòng)劑的親和力顯著增加；對(duì)催產(chǎn)素來說，它也增加穩(wěn)定性。

74. This is most effective if a specific receptor blocking agent is available to counter the effects of a given agonist

在這方面最有效的是利用特效的受體阻滯藥對(duì)抗特定激劑的作用。

75. Keywords Prolactinoma;Nerve growth factor;Receptor;Dopamine receptor agonist;Resistance;Invasiveness;

垂體泌乳素腺瘤;神經(jīng)生長(zhǎng)因子;受體;多巴胺受體激動(dòng)劑;耐受;侵襲性;

76. Keywords polycystic ovary syndrome（PCOS）;gonadotrophin-releasing hormone agonist;ovulation induction;ovarian hyperstimulation syndrome（OHSS）;pregnancy;

多囊卵巢綜合征（PCOS）;促性腺激素釋放素;排卵誘導(dǎo);卵巢過度刺激綜合征（OHSS）;妊娠;

77. dopamine D2 receptor agonist

多巴胺D2受體激動(dòng)劑

78. Keywords dopamine receptor;body temperature regulation;agonist;antagonist;

多巴胺受體;體溫調(diào)節(jié);激動(dòng)劑;拮抗劑;

79. Keywords partial dopamine receptor agonist;schizophrenia;aripiprazole;

多巴胺受體部分激動(dòng)劑;精神分裂癥;阿立哌唑;

80. Evaluation of Clinical Usage of Partial Dopamine Receptor Agonist

多巴胺受體部分激動(dòng)劑的臨床應(yīng)用評(píng)價(jià)